Combined Inhibitors of Serotonin/Norepinephrine Reuptake
DBCAT003877Pharmacologic class
A DrugBank category of 27 drugs. 27 of them are approved.
- Part of
- Serotonin Modulators
What you can answer from here — as of August 09, 2018
Which targets do Combined Inhibitors of Serotonin/Norepinephrine Reuptake share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account